Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Completes Acquisition of Cepheid

NEW YORK (GenomeWeb) ­– Danaher announced Friday that it has completed its $4 billion acquisition of Cepheid.

Cepheid has been merged into Copper Merger Sub, a wholly owned subsidiary of Danaher, resulting in Cepheid becoming an indirect wholly owned subsidiary of Danaher.

Each outstanding share of Cepheid common stock was cancelled — except for shares held by Danaher, Copper Merger Sub, Cepheid, and respective subsidiaries — and converted into $53.00 per share in cash.

Cepheid's common stock will no longer be traded on the Nasdaq.

Danaher's shares rose nearly 2 percent to $78.30 in morning trading on the New York Stock Exchange.